Vantage Consulting Group’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,757
Closed -$228K 85
2024
Q2
$228K Sell
3,757
-201
-5% -$11.4K 0.17% 152
2024
Q1
$225K Sell
3,958
-322
-8% -$19.3K 0.14% 159
2023
Q4
$269K Buy
4,280
+659
+18% +$37.3K 0.18% 97
2023
Q3
$209K Sell
3,621
-155
-4% -$9.77K 0.14% 178
2023
Q2
$235K Buy
3,776
+448
+13% +$29.9K 0.14% 153
2023
Q1
$241K Buy
3,328
+393
+13% +$30.7K 0.14% 172
2022
Q4
$236K Sell
2,935
-626
-18% -$47.9K 0.14% 150
2022
Q3
$237K Buy
3,561
+150
+4% +$11.1K 0.14% 139
2022
Q2
$259K Buy
3,411
+305
+10% +$23.2K 0.15% 107
2022
Q1
$247K Sell
3,106
-873
-22% -$63.5K 0.1% 147
2021
Q4
$292K Buy
3,979
+545
+16% +$36.7K 0.08% 101
2021
Q3
$236K Buy
3,434
+676
+25% +$51.4K 0.05% 152
2021
Q2
$232K Buy
+2,758
New +$230K 0.04% 158
2021
Q1
Sell
-897
Closed -$78K 796
2020
Q4
$78K Buy
+897
New +$77.6K 0.01% 258

Other funds holding INCY

Vantage Consulting Group's INCY Position: Q3 2024 in Review

Vantage Consulting Group sold out of Incyte (INCY) in Q3 2024, closing a stake of 3,757 shares — an estimated $228K sold.

Vantage Consulting Group first reported a position in INCY in Q4 2020 and held it in 14 quarters. The position peaked at $292K in Q4 2021. 592 funds tracked by Wall St. Rank hold INCY as of Q3 2024.

  • Vantage Consulting Group reported no remaining Incyte position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 3,757 Incyte shares in Q3 2024, an estimated $228K.
  • Vantage Consulting Group first reported a position in Incyte in Q4 2020 and held it in 14 quarters.
  • Vantage Consulting Group's Incyte position peaked at $292K in Q4 2021.
  • 592 funds tracked by Wall St. Rank held Incyte as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.